Literature DB >> 4210337

Slime of Pseudomonas aeruginosa: in vivo production.

G Dimitracopoulos, J W Sensakovic, P F Bartell.   

Abstract

Indirect hemagglutination inhibition tests were employed to detect slime in concentrations as low as 1 mug/ml. Increasing concentrations of slime resulted in proportionately greater inhibition of hemagglutination. Peritoneal aspirates and plasma of mice injected with slime were shown to exhibit the inhibitory activity of slime. The rapid dissemination of slime into the peripheral circulation was also indicated by the hemagglutination of mouse erythrocytes by specific anti-slime serum. By similar methods, the inhibitory activity of slime was also detected in peritoneal aspirates and plasma of mice infected with lethal doses of viable Pseudomonas aeruginosa. Furthermore, the inhibitory activity was found to increase with time after viable cell infection, whereas such increases were not detected after the injection of heat-killed organisms. Ferritin-labeled slime antibodies were found to completely surround cells of Pseudomonas aeruginosa obtained from the peritoneal cavity of mice 5 h postinfection.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4210337      PMCID: PMC414971          DOI: 10.1128/iai.10.1.152-156.1974

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  16 in total

1.  TOXICITY OF PSEUDOMONAS AERUGINOSA SLIME.

Authors:  W S CALLAHAN; B BEYERLEIN; J D MULL
Journal:  J Bacteriol       Date:  1964-09       Impact factor: 3.490

2.  The roles of various fractions of Pseudomonas aeruginosa in its pathogenesis.

Authors:  P V LIU; Y ABE; J L BATES
Journal:  J Infect Dis       Date:  1961 Mar-Apr       Impact factor: 5.226

3.  Passive immunization against experimental pseudomonas infection: correlation of protection to verder and evans "o" serotypes.

Authors:  J A Bass; J C McCoy
Journal:  Infect Immun       Date:  1971-01       Impact factor: 3.441

4.  Pseudomonas aeruginosa--its characterization and identification.

Authors:  W C HAYNES
Journal:  J Gen Microbiol       Date:  1951-11

5.  The lethal events in experimental Pseudomonas aeruginosa infection of mice.

Authors:  P F Bartell; T E Orr; M Garcia
Journal:  J Infect Dis       Date:  1968-04       Impact factor: 5.226

6.  Pathology of Pseudomonas infection.

Authors:  F D Foley; K A Greenawald; G Nash; B A Pruitt
Journal:  Tex Med       Date:  1969-10

7.  Review of pseudomonas sepsis in thermal burns: verdoglobin determination and gentamicin therapy.

Authors:  H H Stone
Journal:  Ann Surg       Date:  1966-02       Impact factor: 12.969

8.  The slime of Pseudomonas aeruginosa: biological characterization and possible role in experimental infection.

Authors:  J W Sensakovic; P F Bartell
Journal:  J Infect Dis       Date:  1974-02       Impact factor: 5.226

9.  Composition of Pseudomonas aeruginosa slime.

Authors:  M R Brown; J H Foster; J R Clamp
Journal:  Biochem J       Date:  1969-05       Impact factor: 3.857

10.  Polysaccharide depolymerase associated with bacteriophage infection.

Authors:  P F Bartell; T E Orr; G K Lam
Journal:  J Bacteriol       Date:  1966-07       Impact factor: 3.490

View more
  16 in total

1.  Phagocytosis and killing of Pseudomonas aeruginosa by mouse polymorphonuclear leukocytes in vitro promoted by antiserum to the slime glycolipoprotein.

Authors:  O Bishop; T Orr; P F Bartell
Journal:  Infect Immun       Date:  1982-07       Impact factor: 3.441

Review 2.  Microbial surfaces in relation to pathogenicity.

Authors:  H Smith
Journal:  Bacteriol Rev       Date:  1977-06

3.  Mitogenic effects of glycolipoprotein extract from Pseudomonas aeruginosa.

Authors:  A M Varey; A Cooke; G Dimitrocopoulos; M Papamichail
Journal:  Clin Exp Immunol       Date:  1984-05       Impact factor: 4.330

4.  In vitro effect of the slime of Pseudomonas aeruginosa on the function of human polymorphonuclear neutrophils.

Authors:  P F Laharrague; J X Corberand; G Fillola; B J Gleizes; A M Fontanilles; E Gyrard
Journal:  Infect Immun       Date:  1984-06       Impact factor: 3.441

5.  Biological activity of fragments derived from the extracellular slime glycolipoprotein of Pseudomonas aeruginosa.

Authors:  J W Sensakovic; P F Bartell
Journal:  Infect Immun       Date:  1975-10       Impact factor: 3.441

6.  Ultrastructure of cell envelopes of bacteria of the bovine rumen.

Authors:  K J Cheng; J W Costerton
Journal:  Appl Microbiol       Date:  1975-06

7.  Virulence of different Pseudomonas species in a burned mouse model: tissue colonization by Pseudomonas cepacia.

Authors:  G B Stover; D R Drake; T C Montie
Journal:  Infect Immun       Date:  1983-09       Impact factor: 3.441

8.  Pseudomonas aeruginosa slime glycolipoprotein is a potent stimulant of tumor necrosis factor alpha gene expression and activation of transcription activators nuclear factor kappa B and activator protein 1 in human monocytes.

Authors:  George Lagoumintzis; Myrto Christofidou; George Dimitracopoulos; Fotini Paliogianni
Journal:  Infect Immun       Date:  2003-08       Impact factor: 3.441

9.  Glycolipoprotein from Pseudomonas aeruginosa as a protective antigen against P. aeruginosa infection in mice.

Authors:  J W Sensakovic; P F Bartell
Journal:  Infect Immun       Date:  1977-11       Impact factor: 3.441

10.  In vivo distribution of Pseudomonas aeruginosa slime glycolipoprotein: association with leukocytes.

Authors:  M Lynn; J W Sensakovic; P F Bartell
Journal:  Infect Immun       Date:  1977-01       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.